Table 4.
Telephone survey results related to coronavirus disease 2019
| Analyzing survey data of the participants (n = 414) | Results n(%) |
|---|---|
| COVID-19-related symptoms | |
| Fever | 20 (4.8) |
| Non-productive cough | 8 (1.9) |
| Sputum production | – |
| Sore throat | 9 (2.2) |
| Rhinorrhea | 3 (0.7) |
| Fatigue | 8 (1.9) |
| Arthralgia | 49 (11.8) |
| Myalgia | 15 (3.6) |
| Anosmia/dysgeusia | 3 (0.7) |
| Dyspnea | 1 (0.2) |
| Headache | – |
| Nausea/vomiting | 2 (0.5) |
| Diarrhea | 8 (1.9) |
| Rash | 4 (1) |
| A healthcare worker in the family (household contact) | 9 (2.2) |
| Confirmed diagnosis in the family (household contact) | 17 (4.1) |
| Confirmed diagnosis in relatives or neighbors living in the same apartment | 63 (15.2) |
| History of contact with confirmed cases (clearly stated) | 18 (4.3) |
| Attendance at a hospital with suspicion of COVID-19 | 9 (2.2) |
| History of contact | 6 |
| Chest X-ray performed for COVID-19 | 6 (1.4) |
| History of contact | 4 |
| Consistent with COVID-19 | 1 |
| Computed tomography performed for COVID-19 | 4 (0.9) |
| History of contact | 3 |
| Consistent with COVID-19 | 1 |
| Pharyngeal swab COVID‐19 nucleic acid test | 9 (2.1) |
| History of contact | 6 |
| Positive for COVID-19 | 1 |
| Treatment interruption during the outbreak (antirheumatic drugs) | 59 (14.3) |
| Reason for discontinuation of treatment | |
| Inadequate access to health care | 29 (49.2%) |
| Concern about increased risk | 16 (27.1%) |
| Shortage of medication | 14 (23.7%) |
COVID-19: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease 2019